CHOICE OF THERAPEUTIC STRATEGY IN SEZARY SYNDROME: CASE REPORT
- Authors: Zaslavsky D.V1, Yunovidova A.A2, Wolkenstein P.3, Sydikov A.K1, Skrek S.V2,4, Kovalchuk A.K5, Sobolev A.V6, Salogub G.N7
-
Affiliations:
- SPbSPMU
- NWSMU n.a. I.I. Mechnikov
- Dermatology Service of the Henri Mondor University Hospital
- French Clinic of Skin Diseases n.a. Pierre Wolkenstein
- Dermatovenerologic Dispensary №11 of the Central District of St. Petersburg
- SRI of Medical Mycology n.a. P.N. Kashkin NWSMU .a. I.I. Mechnikov
- FSPbSMU n.a. Acad. I.P. Pavlov
- Issue: No 20 (2016)
- Pages: 53-58
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/289575
- ID: 289575
Cite item
Abstract
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
D. V Zaslavsky
SPbSPMUDepartment of dermatology
A. A Yunovidova
NWSMU n.a. I.I. MechnikovDepartment of dermatology
P. Wolkenstein
Dermatology Service of the Henri Mondor University Hospital
A. K Sydikov
SPbSPMUDepartment of dermatology
S. V Skrek
NWSMU n.a. I.I. Mechnikov; French Clinic of Skin Diseases n.a. Pierre WolkensteinTeaching Assistant at the Department of Dermatovenerology
A. K Kovalchuk
Dermatovenerologic Dispensary №11 of the Central District of St. Petersburg
A. V Sobolev
SRI of Medical Mycology n.a. P.N. Kashkin NWSMU .a. I.I. Mechnikov
G. N Salogub
FSPbSMU n.a. Acad. I.P. PavlovDepartment of Faculty Therapy with course of Endocrinology, Cardiology and Functional Diagnostics n.a. G.F. Lang with the Clinic
References
- Scarisbrick J.J., Kim Y.H., Whittaker S.J., Wood G.S., Vermeer M.H., Prince H.M., Quagiino P. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now? Br. J. Dermatol. 2014;6:1226-36.
- Whittaker S.J., Marsden J.R., Spittle M., Jones R.R. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br. J. Dermatol. 2003; 149:1095-107.
- Girardi M., Edelson R.L., Cutaneous T-Cell Lymphoma: Pathogenesis and Treatment. 0ncology.2000;14:1061-70.
- Trautingera F., Knoblera R., Willemzeb R., Perisc K., Stadlerd R., Larochee L., D'incanf M., Rankig A., Pimpinellih N., Ortiz-Romeroi P., Dummerj R., Estrachk T., Whittakerl S. EORTC consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome. Eur. J. Cancer. 2006;42:1014-30.
- Olsen E.A., Rook A.H., Zic J., Kim Y., Porcu P., Querfeld C., Wood G., Demierre M.F., Pittelkow M., Wilson L.D., Pinter-Brown L., Advani R., Parker S., Kim E.J., Junkins-Hopkins J.M., Foss F., Cacchio P., Duvic M. Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). J Am. Acad. Dermatol. 2011;64:352-404.
- Stadler R., Kremer A. Therapeutic advances in cutaneous T-cell lymphoma (CTCL): from retinoids to rexinoids. Semin. Oncol. 2006; 33:7-10.
- Ashworth J., Booker J., Breathnach S.M. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Br. J. Dermatol. 1988;118:457-70.
- Herrmann J.J., Roenigk H.H. Jr., Honigsmann H. Ultraviolet radiation for treatment of cutaneous T-cell lymphoma. Hematol. Oncol. Clin. North Am.1995;9:1077-88.
- Thomsen K., Hammar H., Molin L., Volden G. Retinoids plus PUVA (Re-PUVA) and PUVA in mycosis fungoides, plaque stage: a report from the Scandinavian mycosis fungoides group. Acta Derm. Venereol. 1989; 69:536-38.
- Lowe N.J., Cripps D.J., Dufton P.A., Vickers C.F Photochemotherapy for mycosis fungoides: a clinical and histological study. Arch. Dermatol. 1979;115:50-3.
- Mangelsdorf D.J., Umesono K., Evans R.M. The retinoid receptors. in: The Retinoids, Biology, Chemistry and Medicine. New York: Raven Press. 1994;2:319-50.
- Farooqui A.A., Antony P., Ong W.Y., Horrocks L.A., Freysz L. Retinoic acid-mediated phospholipase A2 signaling in the nucleus. Brain Res. Rev. 2004;45:179-95.
- Dunn L.K., Gaar L.R., Yentzer B.A., O'Neill J.L., Feldman S.R. Acitretin in dermatology: a review. J. Drugs Dermatol. 2011;10:772-82.
- Cheeley J., Sahn R.E., DeLong L.K., Parker S.R. Acitretin for the treatment of cutaneous T-cell lymphoma. J. Am. Acad. Dermatol. 2013;68:247-54.
- Sokoiowska-Wojdyto M., Lugowska-Umer H., Maciejewska-Radomska A. Oral retinoids and rexinoids in cutaneous T-cell lymphomas. Postepy Dermatol. Alergol. 2013;30:19-29.
- Ларина С.Н., Чебышев Н.В., Ших Е.В., Каркищенко В.Н. Модулирование действия ядерных рецепторов и регуляция биотрансформации веществ. Биомедицина. 2009;1:70-80.
- Beylot-Barry M. Bexarotène: Targretin. Ann. Dermatol. Venerol. 2007;134:987-91.
- Bagot M., Bensussan A. Les lymphomes T épidermotropes comme modèles de progression tumorale. Med. Sci. 2006;22:192-96.
- Bagot M. Les lymphomes cutanés. Paris: Springer, 2013. P 77-91.
Supplementary files
![](/img/style/loading.gif)